About the Authors

Robert De Rose

Affiliation Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia

Caroline S. Fernandez

Affiliation Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia

Miranda Z. Smith

Affiliation Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia

C. Jane Batten

Affiliation Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia

Sheilajen Alcântara

Affiliation Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia

Vivienne Peut

Affiliation Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia

Erik Rollman

Affiliation Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia

Liyen Loh

Affiliation Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia

Rosemarie D. Mason

Affiliation Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia

Kim Wilson

Affiliation National Serology Reference Laboratory, Fitzroy, Victoria, Australia

Matthew G. Law

Affiliation National Centre for HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, New South Wales, Australia

Amanda J. Handley

Medicines Development Ltd, Melbourne, Victoria, Australia

Affiliations Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia, Opal Therapeutics Pty Ltd, Melbourne, Victoria, Australia

Stephen J. Kent

skent@unimelb.edu.au

Affiliation Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia

Competing Interests

SJK spun out a venture capital–backed biotechnology start-up company, OPAL Therapeutics Pty Ltd, to pursue this technology towards clinical trials. SJK, CJB and the University of Melbourne hold shares in this company. AJH has been an employee of OPAL Therapeutics.

Author Contributions

Conceived and designed the experiments: SK. Performed the experiments: RD CF MS CB SA VP ER LL RM KW AH SK. Analyzed the data: ML SK. Wrote the paper: SK. Performed the statistical analyses: ML. Audited the study: AH.